A Study of MK-8527 in Participants With Moderate and Severe Renal Impairment (MK-8527-008)

Clinical trial NCT06295796 · COMPLETED

Trial details

NCT number: NCT06295796
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Renal Impairment

Start date: 2024-06-20
Primary completion: 2025-01-31
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.